新型基因療法使先天性耳聾患者恢復聽力
New gene therapy restores hearing in people born deaf
聽力學領域出現了一項具開創性的醫學進展，為遺傳性耳聾患者帶來了希望。
A groundbreaking medical advancement has emerged in the field of audiology, offering hope to those with hereditary deafness.
研究人員已成功利用基因治療來恢復OTOF基因突變個體的聽力。
Researchers have successfully utilized gene therapy to restore hearing in individuals with mutations in the OTOF gene.
此基因對於產生耳蝸蛋白(otoferlin)至關重要，該蛋白能將聲音信號從內耳傳輸至大腦。
This gene is crucial for creating the otoferlin protein, which transmits sound signals from the inner ear to the brain.
科學家透過一種無害的病毒載體，將具有功能的基因複本傳送至耳蝸毛細胞中，有效修復了生物學上的連結。
By using a harmless viral vector, scientists deliver a functional copy of the gene into the cochlear hair cells, effectively repairing the biological connection.
與繞過受損細胞的傳統人工耳蝸植入物不同，這種精準醫學針對的是聽力喪失的根本病因。
Unlike traditional cochlear implants that bypass damaged cells, this precision medicine targets the root cause of the hearing loss.
儘管此方法目前僅限於OTOF突變，且仍處於臨床試驗階段，但它代表著從單純管理耳聾到有望在分子層面進行矯正的重大轉變。
While this method is currently specific to OTOF mutations and remains in clinical trials, it represents a monumental shift from simply managing deafness to potentially correcting it at a molecular level.
展望未來，將基因檢測整合進聽力學將有望提供更客製化的干預措施，儘管聽障社群內部仍在持續討論此類治療的倫理問題。
As we look toward the future, the integration of genetic testing into audiology promises more tailored interventions, though discussions regarding the ethics of such treatments continue within the Deaf community.
這項發展標誌著再生醫學進入了新紀元，內耳纖細的結構再也不是我們力所不及的了。
This development marks a new era in regenerative medicine, where the delicate structures of the inner ear are no longer beyond our reach.
